Semaglutide drug Wegovy has been available in New Zealand for a couple of months now, and more Kiwis are learning about the effects.

The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer’s, addiction and depression.

General Practice NZ chair Dr Bryan Betty joined the Afternoons team to discuss further - and highlight some potential drawbacks.

LISTEN ABOVE

Semaglutide drug Wegovy has been available in New Zealand for a couple of months now, and more Kiwis are learning about the effects.
The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer’s, addiction and depression.
General Practice NZ chair Dr Bryan Betty joined the Afternoons team to discuss further - and highlight some potential drawbacks.
LISTEN ABOVE

We’re bringing you an exciting new era on Newstalk ZB with Matt Heath & Tyler Adams Afternoons.

With years of media and broadcast experience between them, this team brings a fresh and unique perspective to your weekdays.

Matt and Tyler dive into the latest news stories, share their opinions, and engage with their listeners weekdays on Newstalk ZB.

We’re bringing you an exciting new era on Newstalk ZB with Matt Heath &amp; Tyler Adams Afternoons.
With years of media and broadcast experience between them, this team brings a fresh and unique perspective to your weekdays.
Matt and Tyler dive into the latest news stories, share their opinions, and engage with their listeners weekdays on Newstalk ZB.

Matt Heath and Tyler Adams dive into the latest news stories, share their opinions, and engage with their listeners weekdays on Newstalk ZB.

Matt Heath & Tyler Adams Afternoons

Dr Bryan Betty: General Practice NZ chair on the impact of weight-loss drugs

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/8968b23a-c336-4039-9f14-b35a003c31a2/transcript